- Benzinga•last year
In a report published Friday, Leerink analyst Dan Leonard initiated coverage of TrovaGene, Inc. (NASDAQ: TROV ) with an Outperform rating and price target of $9. According to the Leerink report, "TROV ...
- Insider Monkey•last yearInsiders Are Buying Up Shares Of Sothebys (BID), Summit Hotel Properties Inc (INN), and TrovaGene Inc (TROV)
One important field Insider Monkey follows is insider trades. Ultimately, who else would be most informed about developments in companies than the people most closely associated with these organizations? It comes as no surprise, therefore, that data shows insider purchases can be relatively effective in predicting how a stock performs over the long-term. This is why
We're sorry this is all we were able to find about this topic.
TrovaGene, Inc. (TROVU)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
As of 9:30 AM EST. Market open.
|Bid||0.01 x 100|
|Ask||199,999.00 x 100|
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|